SLT as primary glaucoma treatment may offer reduced cost, better efficacy than eye drops
“With SLT laser, you simply treat the patient,
and the rest is history” Nathan Radcliffe, MD
Japanese hospital conducts world's 1st iPS transplant of visual cells
A Japanese hospital said it has performed the
world's first clinical trial of a transplant of visual cells
derived from induced pluripotent stem cells, or iPS cells, to treat a patient with pigmentary retinal degeneration.
WVU and Pitt team up for laser trial to treat glaucoma
Dr. Tony Realini, professor of ophthalmology and glaucoma
specialist at WVU, will be the principal investigator of
a $15.2 million study on how a treatment called selective laser trabeculoplasty (SLT).
KKR to buy online contact lens retailer 1-800 Contacts
KKR & Co has agreed to acquire 1-800 Contacts
from investment firm AEA Investors LP, the online
contact lens retailer announced on Wednesday, in a deal that a source said was worth more than $3 billion.
Optometry on front line to identify early signs of Alzheimer’s, Parkinson’s
The good news is that a tremendous amount of
research points to several ocular biomarkers for
neurodegenerative disease — and puts optometry center stage in addressing these public health crises in the future.
FDA accepts Biogen’s aducanumab biologics license application for alzheimer's disease with priority review
Biogen announced that the FDA has
accepted the Biologics License Application
for aducanumab, an investigational treatment for Alzheimer’s disease.